Drawing for LNA-ANTIMIR

USPTO serial 79114443

LNA-ANTIMIR

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
LAVACHE, LINDA M
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LNA-ANTIMIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in industry and science; active chemical ingredients for use in the manufacture of pharmaceuticals or pharmaceutical development candidates for treating infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemicals for use in the manufacture of medical and scientific preparations; nucleotides, nucleotide analogues and oligonucleotides for medical research and developmentSECTION 70 - CANCELLED—
005Pharmaceutical preparations for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, gastro-intestinal diseases, diseases of the central nervous system, autoimmune diseases, genetic disorders and malignant diseases; chemical preparations for pharmaceutical, medical and therapeutic purposes, namely, for the treatment of infectious diseases, metabolic disorders, inflammatory diseases, cardiovascular diseases, diseases of the central nervous system autoimmune diseases, genetic disorders and malignant diseasesSECTION 70 - CANCELLED—
042Scientific and technological services, namely, biopharmaceutical research as well as research and design connected thereto, namely, design and development of pharmaceutical products, biomedical and biotechnological analysis and research; development of medical and biomedical products and preparations; biochemical and molecular biological analysis; scientific, biotechnological and biomedical consultancy; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical preparations, methods and productsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 1, 2022DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jul 31, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Nov 7, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 13, 2014FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 24, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 22, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 11, 2014OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 26, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 25, 2013OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 22, 2013MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 22, 2013ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Aug 17, 2012RFNTREFUSAL PROCESSED BY IB—
Jul 27, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 27, 2012RFRRREFUSAL PROCESSED BY MPU—
Jul 27, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 27, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 26, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2012DOCKASSIGNED TO EXAMINER—
Jul 23, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2012LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jul 19, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance